# A Study in Healthy Men and Women to Test How BI 3000202 is Taken up and Processed by the Body

> **NCT07273474** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 3000202
- **DRUG:** BI 3000202 [14C]-labelled

## Key facts

- **NCT ID:** NCT07273474
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-12-30
- **Primary completion:** 2026-03-05
- **Final completion:** 2026-03-25
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07273474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07273474, "A Study in Healthy Men and Women to Test How BI 3000202 is Taken up and Processed by the Body". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07273474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*